NEW
YORK, June 18, 2024 /PRNewswire/ -- Rowley Law
PLLC is investigating potential securities law violations by Silk
Road Medical, Inc. (NASDAQ: SILK) and its board of directors
concerning the proposed acquisition of the company by Boston
Scientific Corporation (NYSE: BSX). Stockholders will receive
$27.50 for each share of Silk Road
Medical stock that they hold. The transaction is valued at
approximately $1.26 billion and is
expected to close in the second half of 2024.
If you are a stockholder of Silk Road Medical, Inc. and are
interested in obtaining additional information regarding this
investigation, please visit us
at: http://www.rowleylawpllc.com/investigation/silk/. You may
also contact Shane Rowley, Esq. at
Rowley Law PLLC, 50 Main Street Suite 1000, White Plains, NY 10606, by email at
info@rowleylawpllc.com, or by telephone at 914-400-1920 or
844-400-4643 (toll-free).
Rowley Law PLLC represents shareholders nationwide in class
actions and derivative lawsuits in complex corporate litigation.
For more information about the firm and its attorneys, please visit
http://www.rowleylawpllc.com.
Attorney Advertising. Prior results do not guarantee a similar
outcome.
View original
content:https://www.prnewswire.com/news-releases/alert-rowley-law-pllc-is-investigating-proposed-acquisition-of-silk-road-medical-inc-302175870.html
SOURCE Rowley Law PLLC